# FDA Inspection 1206677 - Veloxis Pharmaceuticals, Inc. - May 19, 2023

Source: https://www.keypedia.com/records/fda_inspections/veloxis-pharmaceuticals-inc/54f8bb21-c708-479e-8fae-1b3be7742d9f
Source feed: FDA_Inspections

> FDA Inspection 1206677 for Veloxis Pharmaceuticals, Inc. on May 19, 2023. Classification: No Action Indicated (NAI).

---

## Details

- Record Type: FDA Inspection
- Inspection ID: 1206677
- Company Name: Veloxis Pharmaceuticals, Inc.
- Inspection Date: 2023-05-19
- Classification: No Action Indicated (NAI)
- Project Area: Bioresearch Monitoring
- Product Type: Drugs
- Office Name: Center for Drug Evaluation and Research

## Related Documents

- [FDA Inspection 731057 - 2011-06-15](https://www.keypedia.com/records/fda_inspections/veloxis-pharmaceuticals-inc/41df9847-39e1-4dc8-a1b1-107492d34fe0)

Company: https://www.keypedia.com/companies/veloxis-pharmaceuticals-inc/e981699a-6ac0-43cd-b27c-86cfbc90d3af

Office: https://www.keypedia.com/offices/center-for-drug-evaluation-and-research/cd980d74-1cbf-4226-ba9a-9045324c236c